CD83 and Behcet disease: The frequency of CD83+ cells was downregulated in butyrate intraperitoneally-treated BD mice compared to untreated BD mice (23.83 ± 9.32% vs. 40.72 ± 8.91%) but the difference was not statistically significant (Figure 5A).